vs
Side-by-side financial comparison of DiamondRock Hospitality Co (DRH) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
DiamondRock Hospitality Co is the larger business by last-quarter revenue ($258.2M vs $185.2M, roughly 1.4× AMICUS THERAPEUTICS, INC.). DiamondRock Hospitality Co runs the higher net margin — 5.6% vs 0.9%, a 4.7% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 1.3%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -8.6%).
DiamondRock Hospitality Co is a US-based real estate investment trust owning and operating a portfolio of premium upscale hotels and resorts. Its properties are mainly located in major urban tourist and business hubs nationwide, catering to both leisure and corporate clientele seeking high-quality accommodation services.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
DRH vs FOLD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $258.2M | $185.2M |
| Net Profit | $14.5M | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | 11.1% | 8.6% |
| Net Margin | 5.6% | 0.9% |
| Revenue YoY | 1.3% | 23.7% |
| Net Profit YoY | 22.0% | -88.5% |
| EPS (diluted) | $0.07 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $258.2M | — | ||
| Q4 25 | $274.5M | $185.2M | ||
| Q3 25 | $285.4M | $169.1M | ||
| Q2 25 | $305.7M | $154.7M | ||
| Q1 25 | $254.9M | $125.2M | ||
| Q4 24 | $279.1M | $149.7M | ||
| Q3 24 | $285.1M | $141.5M | ||
| Q2 24 | $309.3M | $126.7M |
| Q1 26 | $14.5M | — | ||
| Q4 25 | $26.2M | $1.7M | ||
| Q3 25 | $22.5M | $17.3M | ||
| Q2 25 | $40.8M | $-24.4M | ||
| Q1 25 | $11.9M | $-21.7M | ||
| Q4 24 | $-11.2M | $14.7M | ||
| Q3 24 | $26.4M | $-6.7M | ||
| Q2 24 | $24.5M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% |
| Q1 26 | 11.1% | — | ||
| Q4 25 | 8.9% | 8.6% | ||
| Q3 25 | 8.1% | 20.3% | ||
| Q2 25 | 13.7% | -6.1% | ||
| Q1 25 | 4.3% | -6.3% | ||
| Q4 24 | -3.7% | 10.7% | ||
| Q3 24 | 9.5% | 15.3% | ||
| Q2 24 | 8.4% | 11.8% |
| Q1 26 | 5.6% | — | ||
| Q4 25 | 9.5% | 0.9% | ||
| Q3 25 | 7.9% | 10.2% | ||
| Q2 25 | 13.4% | -15.8% | ||
| Q1 25 | 4.7% | -17.3% | ||
| Q4 24 | -4.0% | 9.8% | ||
| Q3 24 | 9.3% | -4.8% | ||
| Q2 24 | 7.9% | -12.4% |
| Q1 26 | $0.07 | — | ||
| Q4 25 | $0.12 | $0.00 | ||
| Q3 25 | $0.10 | $0.06 | ||
| Q2 25 | $0.18 | $-0.08 | ||
| Q1 25 | $0.04 | $-0.07 | ||
| Q4 24 | $-0.06 | $0.05 | ||
| Q3 24 | $0.11 | $-0.02 | ||
| Q2 24 | $0.10 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $39.3M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | $1.4B | $274.2M |
| Total Assets | $3.0B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $39.3M | — | ||
| Q4 25 | $68.1M | $293.5M | ||
| Q3 25 | $145.3M | $263.8M | ||
| Q2 25 | $52.4M | $231.0M | ||
| Q1 25 | $100.6M | $250.6M | ||
| Q4 24 | $81.4M | $249.9M | ||
| Q3 24 | $75.3M | $249.8M | ||
| Q2 24 | $125.2M | $260.1M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $392.7M | ||
| Q3 25 | $1.1B | $392.0M | ||
| Q2 25 | $1.0B | $391.3M | ||
| Q1 25 | $1.1B | $390.7M | ||
| Q4 24 | $1.1B | $390.1M | ||
| Q3 24 | $1.1B | $389.5M | ||
| Q2 24 | $1.2B | $388.9M |
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.4B | $274.2M | ||
| Q3 25 | $1.6B | $230.4M | ||
| Q2 25 | $1.6B | $204.3M | ||
| Q1 25 | $1.6B | $193.6M | ||
| Q4 24 | $1.6B | $194.0M | ||
| Q3 24 | $1.6B | $178.8M | ||
| Q2 24 | $1.6B | $132.5M |
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $949.9M | ||
| Q3 25 | $3.1B | $868.8M | ||
| Q2 25 | $3.1B | $815.3M | ||
| Q1 25 | $3.1B | $789.8M | ||
| Q4 24 | $3.2B | $785.0M | ||
| Q3 24 | $3.2B | $786.6M | ||
| Q2 24 | $3.2B | $749.5M |
| Q1 26 | — | — | ||
| Q4 25 | 0.76× | 1.43× | ||
| Q3 25 | 0.70× | 1.70× | ||
| Q2 25 | 0.65× | 1.92× | ||
| Q1 25 | 0.70× | 2.02× | ||
| Q4 24 | 0.69× | 2.01× | ||
| Q3 24 | 0.67× | 2.18× | ||
| Q2 24 | 0.71× | 2.93× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $16.3M |
| Free Cash FlowOCF − Capex | — | $16.0M |
| FCF MarginFCF / Revenue | — | 8.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $67.9M | $16.3M | ||
| Q3 25 | $74.6M | $35.7M | ||
| Q2 25 | $73.6M | $-26.5M | ||
| Q1 25 | $27.6M | $7.8M | ||
| Q4 24 | $75.8M | $-3.9M | ||
| Q3 24 | $61.7M | $-23.0M | ||
| Q2 24 | $55.7M | $22.7M |
| Q1 26 | — | — | ||
| Q4 25 | $47.3M | $16.0M | ||
| Q3 25 | $54.9M | $35.3M | ||
| Q2 25 | $57.9M | $-28.9M | ||
| Q1 25 | $2.0M | $7.5M | ||
| Q4 24 | $52.6M | $-4.2M | ||
| Q3 24 | $39.0M | $-23.3M | ||
| Q2 24 | $38.8M | $21.6M |
| Q1 26 | — | — | ||
| Q4 25 | 17.2% | 8.6% | ||
| Q3 25 | 19.2% | 20.9% | ||
| Q2 25 | 18.9% | -18.7% | ||
| Q1 25 | 0.8% | 6.0% | ||
| Q4 24 | 18.9% | -2.8% | ||
| Q3 24 | 13.7% | -16.5% | ||
| Q2 24 | 12.5% | 17.0% |
| Q1 26 | — | — | ||
| Q4 25 | 7.5% | 0.2% | ||
| Q3 25 | 6.9% | 0.2% | ||
| Q2 25 | 5.1% | 1.6% | ||
| Q1 25 | 10.0% | 0.2% | ||
| Q4 24 | 8.3% | 0.2% | ||
| Q3 24 | 7.9% | 0.3% | ||
| Q2 24 | 5.5% | 0.9% |
| Q1 26 | — | — | ||
| Q4 25 | 2.59× | 9.62× | ||
| Q3 25 | 3.31× | 2.06× | ||
| Q2 25 | 1.80× | — | ||
| Q1 25 | 2.33× | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | 2.33× | — | ||
| Q2 24 | 2.27× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DRH
| Rooms | $164.1M | 64% |
| Food and beverage | $67.2M | 26% |
| Other | $26.9M | 10% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
